| Company/Division name | Moderna Products |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 35 |
| Year reshoring announced: | 2015 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 6.5 |
| Country(ies) from which reshored: | Belgium |
| City reshored to: | Gaffney |
| State(s) reshored to: | SC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Plastic & Rubber Products, Miscellaneous – subset non Hobbies, pet products industry |
| Product(s) reshored | plastic pet products |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Infrastructure, Proximity to customers/market, Skilled workforce availability/training, U.S. biggest market for pet products |
